Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Investigation Into Unexplained Anemia in Diabetes Treated With Erythropoietin
2005-003057-28Phase 4Unknown
- Sponsor
- Aintree University Hospital
- Start
- Jul 2005
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of epoetin beta in Unexplained anemia of aging (UAA), sponsored by Aintree University Hospital. Primary endpoint: Rise in Haemoglobin levels. Status: unknown.
02
Drugs
epoetin beta
03
Conditions
Unexplained anemia of aging (UAA)
Beyond the preview
Go deeper on 2005-003057-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003057-28.